Proteomics and Metabolomics in Type 1 Diabetes and Its Complications
The summary for the Proteomics and Metabolomics in Type 1 Diabetes and Its Complications grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Proteomics and Metabolomics in Type 1 Diabetes and Its Complications: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Eye Institute (NEI), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Neurological Disorders and Stroke (NINDS), and National Institute of Child Health and Human Development (NICHD) encourage the scientific community to use proteomics technologies to study type 1 diabetes (T1D) and its complications. Proteomic technologies have been successfully used for the identification of cancer biomarkers, for the identification of novel drug targets and for studying several biological processes relevant to human health. High throughput metabolic profiling has been recently implemented for metabolomic studies. However, as of today these technologies have been applied to study T1D and its complication only in a limited way. Moreover, currently available proteomic and metabolomic technologies represent a great opportunity for advancing the field of T1D and its complications. This RFA intends to promote the use of these technologies to study T1D and its complications emphasizing the importance of collaborative efforts between investigators with expertise in proteomics or metabolomics and investigators with expertise in T1D.
| Federal Grant Title: | Proteomics and Metabolomics in Type 1 Diabetes and Its Complications |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Income Security and Social Services Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-DK-03-024 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.83793.847 |
| CFDA Descriptions: | Heart and Vascular Diseases Research 93.847 Diabetes, Endocrinology and Metabolism Research |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Mar 18, 2004 |
| Posted Date: | Oct 24, 2003 |
| Creation Date: | Apr 17, 2004 |
| Archive Date: | Apr 17, 2004 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders |
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster